FDA Weighs Pulling Pfizer’s Covid Vaccine for Kids Under Age 5

Aug. 12, 2025, 12:16 PM UTC

The Food and Drug Administration is considering revoking Pfizer Inc.’s authorization to sell its Covid vaccine for children under the age of 5, a move that would leave healthy kids with no available shots.

The agency told Pfizer it might not renew the pandemic-era authorization covering the youngest children, the company said in a statement. Pfizer has requested the authorization stay in place through the coming fall season and is “currently in discussions with the agency on potential paths forward,” the company said.

If Pfizer’s vaccine is no longer available for children as young as six months, kids with ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.